Model N to Present at the JMP Securities Technology Conference
Get Alerts MODN Hot Sheet
Join SI Premium – FREE
SAN MATEO, Calif.--(BUSINESS WIRE)-- Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions for life sciences and high tech companies, today announced that Jason Blessing, president and CEO, will present at the JMP Securities Technology Conference in San Francisco, CA.
This presentation is scheduled for Monday, February 24, 2020, at 10:00 a.m. PT or 1:00 p.m. ET. A live webcast of the presentation will be accessible from the investor relations page of the Model N website at https://investor.modeln.com/.
About Model N
Model N is a leading provider of cloud revenue management solutions for life sciences and high tech companies. Our software helps companies drive mission-critical business processes such as pricing, quoting, contracting, regulatory compliance, rebates and incentives. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical technology, semiconductor, and high tech manufacturing across more than 120 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com.
Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200213005860/en/
Investor Relations Contact:
Gwyn Lauber
Model N, Inc.
650-610-4998
[email protected]
Media Contact:
Laura Ruark
Bospar
[email protected]
Source: Model N, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Slate Grocery REIT Announces Receipt of Interim Order, and Provides Meeting and Circular Details
- Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy
- See It, Try It, Compare It: SIVP Brings CHERY’s “Technology. For Family” to Life
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share